[1]
Ooi, X.Y. et al. 2022. SEVERE INSULIN RESISTANCE REQUIRING HIGH DOSE INSULIN IMPROVED WITH ADD-ON EMPAGLIFOZIN THERAPY: A CASE REPORT. Journal of the ASEAN Federation of Endocrine Societies. 34, 2 (Jun. 2022), 55.